Please check your internet connection and try again.
# Lorazepam (Representative Benzodiazepine)
## Overview
Lorazepam is a benzodiazepine with anxiolytic, sedative, hypnotic, amnestic, and anticonvulsant properties. It acts by enhancing the effect of the neurotransmitter gamma-aminobutyric acid (GABA) at the GABAA receptor.
## Primary Indications
* Anxiety disorders
* Insomnia due to anxiety
* Status epilepticus
* Preoperative sedation
* Management of agitation
## Adult Dosing
* **Anxiety:** 1-4 mg orally, IM, or IV every 6-8 hours.
* **Insomnia:** 2-4 mg orally at bedtime.
* **Status Epilepticus:** 4 mg IM or IV, may repeat in 5-10 minutes if seizures persist, not to exceed 8 mg in a 24-hour period.
* **Preoperative Sedation:** 2-4 mg IM 2 hours before surgery, or 2 mg orally/IM/IV 1-2 hours before surgery.
* **Agitation:** 0.044 mg/kg IM or IV every 12 hours, not to exceed 4 mg per dose.
## Pediatric Dosing
* **Status Epilepticus:** 0.1 mg/kg IM or IV every 5-10 minutes, not to exceed 4 mg per dose. Doses may be repeated once. Maximum dose not established.
* **Anxiety/Sedation:** Dosing is highly variable and should be individualized. Limited data supports use in pediatric patients.
## Dose Adjustments
* **Hepatic Impairment:** Use with caution; dose reduction may be necessary.
* **Renal Impairment:** No specific dose adjustment recommended, but use with caution.
## Contraindications
* Hypersensitivity to lorazepam or other benzodiazepines.
* Acute narrow-angle glaucoma.
* Concurrent use with strong CYP3A4 inhibitors.
* Severe respiratory insufficiency.
## Adverse Effects
* **Common:** Sedation, dizziness, weakness, unsteadiness, amnesia.
* **Serious:** Respiratory depression, paradoxical reactions (agitation, aggression), dependence and withdrawal symptoms, potential for abuse.
## Key Drug Interactions
* **CNS Depressants (opioids, alcohol, barbiturates, other sedatives):** Additive CNS depression, increased risk of respiratory depression and sedation.
* **CYP3A4 Inhibitors (e.g., ketoconazole, ritonavir):** May increase lorazepam levels.
* **Theophylline/Aminophylline:** May antagonize the sedative effects of lorazepam.
## Monitoring
* Level of consciousness, respiratory rate, and oxygen saturation.
* Signs of dependence and withdrawal if used long-term or abruptly discontinued.
* Paradoxical reactions.
## Clinical Pearls
* Lorazepam has a relatively long half-life, which can lead to accumulation, especially in elderly patients or those with hepatic impairment.
* Intramuscular (IM) absorption is reliable and more rapid than oral absorption. Intravenous (IV) administration can lead to rapid onset of action but carries a higher risk of respiratory depression.
* Avoid abrupt discontinuation after prolonged use to prevent withdrawal symptoms. Tapering is recommended.
***
**Disclaimer:** This information is intended for healthcare professionals. Always consult the most current prescribing information and institutional protocols before administering any medication.
